Deutsche Bank
ZBIO

Deutsche Bank’s Zenas BioPharma ZBIO Stock Holding History

Deutsche Bank’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$733K Buy
28,881
+9,615
+50% +$191K ﹤0.01% 2559
2026
Q1 		$377K Buy
19,266
+6,485
+51% +$146K ﹤0.01% 2722
2025
Q4 		$464K Buy
12,781
+554
+5% +$18.2K ﹤0.01% 2611
2025
Q3 		$271K Buy
12,227
+11,947
+4,267% +$194K ﹤0.01% 2904
2025
Q2 		$2.71K Sell
280
-22,710
-99% -$221K ﹤0.01% 3562
2025
Q1 		$182K Hold
22,990
– – ﹤0.01% 2995
2024
Q4 		$188K Buy
+22,990
New +$359K ﹤0.01% 3111

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deutsche Bank's ZBIO Position: Q2 2026 in Review

Deutsche Bank increased its Zenas BioPharma (ZBIO) stake by 50% in Q2 2026, buying an estimated $191K and bringing the position to 28,881 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #2559.

Deutsche Bank first reported a position in ZBIO in Q4 2024 and has held it in 7 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Deutsche Bank held 28,881 shares of Zenas BioPharma worth $733K as of Q2 2026.
  • Deutsche Bank bought 9,615 Zenas BioPharma shares in Q2 2026, an estimated $191K.
  • Zenas BioPharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2559 holding.
  • Deutsche Bank first reported a position in Zenas BioPharma in Q4 2024 and has held it in 7 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.